Antineoplastic Combined Chemotherapy ProtocolsAntineoplastic AgentsEmployer Health CostsCisplatinDoxorubicinChemotherapy, AdjuvantEtoposideDrug Resistance, NeoplasmPrescription FeesCell Line, TumorNeoplasmsAntineoplastic Agents, PhytogenicPaclitaxelDrug Screening Assays, AntitumorDrug Delivery SystemsBreast NeoplasmsCell SurvivalApoptosisCombined Modality TherapyFluorouracilOvarian NeoplasmsCyclophosphamideTreatment OutcomeTumor Cells, CulturedDose-Response Relationship, DrugNeoadjuvant TherapyDisease-Free SurvivalGene Expression Regulation, NeoplasticCell ProliferationNeoplasm StagingSurvival AnalysisPrognosisSurvival RateLung NeoplasmsDrug Administration ScheduleMethotrexateCarboplatinInduction ChemotherapyVinblastineNeoplasm Recurrence, LocalTaxoidsIfosfamideBleomycinDeoxycytidineOrganoplatinum CompoundsAntimetabolites, AntineoplasticAnthracyclinesAntineoplastic Agents, AlkylatingChemotherapy, Cancer, Regional PerfusionCytarabineSalvage TherapyCarcinoma, Non-Small-Cell LungFollow-Up StudiesNeoplasm MetastasisTesticular NeoplasmsVomitingNeutropeniaTransplantation, AutologousAdenocarcinomaNauseaLymphoma, Non-HodgkinRadiotherapy, AdjuvantHodgkin DiseaseTime FactorsColorectal NeoplasmsRadiotherapyAntibiotics, AntineoplasticDacarbazineClinical Trials as TopicProspective StudiesNeoplasms, Germ Cell and EmbryonalCarmustineLomustineGranulocyte Colony-Stimulating FactorCamptothecinKaplan-Meier EstimatePlatinum CompoundsBrain NeoplasmsBone NeoplasmsInfusions, Intra-ArterialOsteosarcomaMelphalanLeukopeniaAntiemeticsMitomycinThiotepaTumor Markers, BiologicalLiver NeoplasmsHematopoietic Stem Cell TransplantationDrug TherapyPeritoneal NeoplasmsMitoxantroneInfusions, IntravenousLymphatic MetastasisRecurrenceStomach NeoplasmsTegafurPalliative CareAntibodies, Monoclonal, HumanizedGerminoma